6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
5h ago	Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
6h ago	Refers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
8h ago	The 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
16h ago	Buffalo Potash Files Annual Information Form and New Technical Report
17h ago	Ionik Announces 30-Day Extension of Senior Debt Facility

About

64.44CHF-0.72 -1.10%

Closed • Updated at 19:33 GMT+00:00

Market Cap$36.03B

P/E Ratio37.30

Volume518.3K

Beta0.51

RSI47.17

Gross Margin46.97%

Health TechnologyPharmaceuticals: Major

Sandoz Group Ltd — investor relations, events, news, and company updates on 6ix.

Latest News

Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates

Sandoz Canada launches first ophthalmology biosimilar

Sandoz CEO, Speaking at 44th Annual J.P. Morgan Healthcare Conference, Will Outline Plans to Capitalize on Unprecedented Golden Decade of Affordable Medicines Opportunity

Polpharma Biologics Confirms U.S. Launch of Tyruko® (natalizumab), the First and Only Biosimilar for Multiple Sclerosis

In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties

Community Chat

Ask AI